期刊文献+

GPR30在妊娠期胎盘中的表达及其对滋养细胞侵袭能力影响的研究 被引量:1

The research about the expression of GPR30 protein in human placenta and its effect on human trophoblast cells invasion
下载PDF
导出
摘要 目的:探讨G-蛋白偶联受体30(GPR30)在妊娠期胎盘中的表达,以及其对人胎盘滋养细胞侵袭力的影响。方法:免疫组化法检测早孕期绒毛、正常产妇胎盘和重度子痫前期患者胎盘组织中GPR30表达。用17-β-雌二醇(17β-E2)、GPR30激动剂G1和阻滞剂G15预处理体外培养绒毛组织和人绒毛外滋养细胞株HTR8/SVneo。显微镜下观察体外绒毛组织滋养细胞生长侵袭范围,Transwell侵袭实验检测HTR8/SVneo细胞侵袭能力。免疫荧光法检测绒毛组织和HTR8/SVneo细胞中GPR30蛋白表达。Western blot法检测HTR8/SVneo细胞中GPR30和MMP-9蛋白表达。结果:GPR30在早期绒毛组织和正常末期胎盘滋养细胞上都有表达,且早孕期的表达水平高于正常末期胎盘,但在重度子痫前期胎盘上GPR30蛋白表达明显减少。E2及GPR30激动剂G1可增加滋养细胞的侵袭能力,阻滞剂G15则可下调其侵袭性;E2、G1可诱导滋养细胞GPR30蛋白表达上调,而G15则下调其表达。GPR30蛋白水平与侵袭相关蛋白MMP-9表达水平有相关性。结论:GPR30可能参与人类滋养细胞侵袭力的调节,对滋养细胞的侵袭力有正性促进作用。 Objective:To characterise the expression of G-Protein Coupled Receptor 30 (GPR30) in human placenta, and to determine the role of GPR30 in trophoblast invasion. Meth- ods:Placentas from first trimester, normal term and pregnancies complicated with pre-eclampsia were used in the study. The effect of 17 ^-estradiol ( E2 ), GPR30 agonist G1 and GPR30 inhibitor G15 on invasion of first trimester villous explants and human trophoblast cell line HTR8/SVneo were determined using in vitro invasion assays. Immunofluorescence and Western blot were used to investigate the GPR30 protein expression. Results:GPR30 protein expression was significantly lower in term placentas from pregnnacies complicated by pre-eclampsia compared to placentas from first trimester and normal term pregnancies. E2 and G1 treatment significantly increased the invasiveness of trophoblast cells. In contrast, the antagonist G15 significantly decreased tropho- blast invasion. In addition, E2 and G1 treatment increased while G15 decreased GPR30 protein ex- pression. Meanwhile, the results also implied that GPR30 involves in regulating the expression of MMP-9. Conclusion: GPR30 plays a role in trophoblast invasion, the up-regulation of GPR30 pro- tein level could increase trophoblast invasion.
出处 《现代妇产科进展》 CSCD 北大核心 2015年第3期161-166,共6页 Progress in Obstetrics and Gynecology
基金 国家自然科学基金(No:81100444 No:81370732) 重庆市自然科学基金资助项目(CSTC 2011BB5121) 重庆市卫生局科研基金资助项目(No:2011-2-046)
关键词 GPR30 滋养细胞 侵袭力 GPR30 Trophoblast cells Invasion
  • 相关文献

参考文献27

  • 1Bjornstrom L,Sjoberg M.Mechanisms of estrogen receptor signaling:convergence of genomic and nongenomic actions on target genes[J].Mol Endocrinol,2005,19(4):833-842.
  • 2Prossnitz ER,Arterburn JB,Smith HO,et al.Estrogen signaling through the transmembrane G protein-coupled receptor GPR30[J].Annu Rev Physiol,2008,70:165-190.
  • 3Scaling AL,Prossnitz ER,Hathaway HJ.GPER mediates estrogen-induced signaling and proliferation in human breast epithelial cells and normal and malignant breast[J].Hormones Cancer,2014,5(3):146-160.
  • 4Ohshiro K,Schwartz AM,Levine PH,et al.Alternate estrogen receptors promote invasion of inflammatory breast cancer cells via non-genomic signaling[J].PLo S One,2012,7(1):e30725.
  • 5He YY,Cai B,Yang YX,et al.Estrogenic G protein-coupled receptor 30 signaling is involved in regulation of endometrial carcinoma by promoting proliferation,invasion potential,and interleukin-6 secretion via the MEK/ERK mitogen-activated protein kinase pathway[J].Cancer Sci,2009,100(6):1051-1061.
  • 6Du GQ,Zhou L,Chen XY,et al.The G protein-coupled receptor GPR30 mediates the proliferative and invasive effects induced by hydroxytamoxifen in endometrial cancer cells[J].Biochem Biophys Res Commun,2012,420(2):343-349.
  • 7Filardo EJ,Quinn JA,Bland KI,et al.Estrogen-induced activation of Erk-1 and Erk-2 requires the G protein-coupled receptor homolog,GPR30,and occurs via trans-activation of the epidermal growth factor receptor through release of HB-EGF[J].Mol Endocrinol,2000,14(10):1649-1660.
  • 8Filardo EJ,Quinn JA,Frackelton AR.Jr,et al.Estrogen action via the G protein-coupled receptor,GPR30:stimulation of adenylyl cyclase and c AMP-mediated attenuation of the epidermal growth factor receptor-to-MAPK signaling axis[J].Mol Endocrinol,2002,16(1):70-84.
  • 9Prossnitz ER,Barton M.Estrogen biology:new insights into GPER function and clinical opportunities[J].Mol Cell Endocrinol,2014,389(1-2):71-83.
  • 10Meyer MR,Prossnitz ER,Barton M.The G protein-coupled estrogen receptor GPER/GPR30 as a regulator of cardiovascular function[J].Vascular Pharmacol,2011,55(1):17-25.

二级参考文献11

  • 1Guillermo N, Lingegowda S. Estrogen cycle modulates ovarian carcinoma growth. Clin Cancer Res 2009; 15(9): 2971-2977.
  • 2Maggiolini M, Picard D. The unfolding stories of GPR30, a new membrane-bound estrogen receptor. J Endocrinol 2010; 204: 105-114.
  • 3Carmeci C, Thompson DA, Ring HZ, Francke U, Weigel R. Identification of a gene (GPR30) with homology to the Gprotein-coupled receptor superfamily associated with estrogen receptor expression in breast cancer. Genomics 1997; 45: 607-617.
  • 4Yager JD, Davidson NE. Estrogen carcinogenesis in breast cancer. N Enel J Med 2006: 354: 270-282.
  • 5Wang C, Prossnitz ER, Roy SK. G protein-coupled receptor 30 expression is required for estrogen stimulation of primordial follicle formation in the hamster ovary. Endocrinology 2008; 149(9): 4452-4461.
  • 6He YY, Cai B, Yang YX, Liu XL, Wan XP. Estrogenic G protein-coupled receptor 30 signaling is involved in regulation of endometrial carcinoma by promoting proliferation, invasion potential, and interleukin-6 secretion via the MEK/ ERK mitogen-activated protein kinase pathway. Cancer Sci 2009; 100(6): 1051-1061.
  • 7Lazari MF, Lucas TF, Yasuhara F, Gomes GR, Siu ER, Royer C, Femandes SA, Porto CS. Estrogen receptors and function in the male reproductive system. Arq Bras Endocrinol Metab 2009; 53(8): 923-933.
  • 8Smith HO, Leslie KK, Singh M, Qualls CR, Revankar CM, Joste NE. GPR30: a novel indicator of poor survival for endometrial carcinoma. Am J Obstet Gynecol 2007; 196(386): 9-11.
  • 9Chen H (陈虹). The research progress of a novel estrogen receptor GPR30. J Endoc Surg (内分泌外科杂志) 2008; 2 (2): 131-133 (Chinese, English abstract).
  • 10Smith HO, Arias-Pulido H, Kuo DY, Howard T, Quails CR, Lee S J, Verschraegen CF, Hathaway HJ, Joste NE, Prossnitz ER. GPR30 predicts poor survival for ovarian cancer. Gynecol Oncol 2009; 114: 465-471.

共引文献6

同被引文献7

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部